Replies to post #385976 on NorthWest Biotherapeutics Inc (NWBO)

[anders2211]

Well She/the company is already in Direct contradiction with alt of the rules of 42 CFR part 11, just look at this “ General Requirements (42 CFR Part 11)

I know they are to all of our frustration.

So if they have new endpoint it should be listed… but as everybody knows, Linda doesnt give a s… about rules…

I have never asserted that NWBO/LP is such a star in following the rules precisely and with great enthusiasm they don't. The late submission of 10Q comes to mind. By the way, the non-compliance of not submitting trial data is a much worse offense than not updating ClinicalTrials.gov with the primary Completion Date within 30 days.